| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f47c750954e13a1ed0be96c1bf1c51c7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| filingDate |
2022-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_082e4c909332cde9451e5ddd6cdcfe96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c54ba877ce248a293fa22a3b02e36aef |
| publicationDate |
2022-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022236176-A2 |
| titleOfInvention |
Fxa protein for treating and/or preventing covid-19 |
| abstract |
Provided herein are, inter alia, methods and compositions useful for treating or preventing COVID-19 in a subject in need thereof. The compositions include Factor Xa (FXa) protein or functional portion thereof. The compositions may further include an anticoagulant, particularly an indirect inhibitor of FXa. |
| priorityDate |
2021-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |